# Target Healthcare REIT PLC (THRL)

**Page:** https://fundology.uk/fund/thrl · ISIN GB00BJGTLF51

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, THRL (Target Healthcare REIT PLC, ISIN GB00BJGTLF51) closed at £1.17 on the London Stock Exchange. Over the five years to 13/11/2026 its price changed by −1.5% (income paid out is not included), or −23.1% after UK CPIH inflation.

## Summary

Target Healthcare REIT PLC is an investment trust. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Latest close: **£1.17** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | THRL |
| ISIN | GB00BJGTLF51 |
| Category | Property & infrastructure |
| Type | Investment trust |
| Domicile | United Kingdom |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +22.35% | +18.02% | price only |
| 3 years | +48.72% | +34.37% | price only |
| 5 years | -1.52% | -23.13% | price only |

Returns: worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Target Healthcare REIT PLC in pounds (price only, income paid out not included): 2022 −32.0%, 2023 +7.6%, 2024 −2.8%, 2025 +16.7%; 2026 to 13/11/2026 +19.1%. Returns of Target Healthcare REIT PLC in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +17.1%; to 30/09/2025: +6.4%; to 30/09/2024: +20.8%; to 30/09/2023: −17.2%; to 30/09/2022: −20.4%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -32.0% | -37.8% | Price |
| 2023 | +7.6% | +3.3% | Price |
| 2024 | -2.8% | -6.1% | Price |
| 2025 | +16.7% | +12.7% | Price |
| 2026 to 13/11/2026 | +19.1% | +15.3% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 18.31% | -8.05% |
| 3 years | 19.88% | -12.23% |
| 5 years | 23.33% | -44.65% |

## Largest fall

Volatility of Target Healthcare REIT PLC in pounds, annualised from weekly returns to 13/11/2026: 18.3% over 1 year, 19.9% over 3 years, 23.3% over 5 years. Largest fall in the price of Target Healthcare REIT PLC since November 2021, in pounds: −44.6% from 19/11/2021 to 24/03/2023. The lowest 12-month return of Target Healthcare REIT PLC in pounds (price only, income paid out not included) since January 2021 was −41.1% (12 months to 18/08/2023); the highest was +33.2% (12 months to 27/06/2025). On 13/11/2026 the price of Target Healthcare REIT PLC was 4.0% below its highest weekly close since November 2021 (19/11/2021), in pounds.

## Charges & eligibility

- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## Questions people ask

**What is the ISIN of THRL?**

The ISIN of THRL is GB00BJGTLF51. An ISIN identifies one exact share class of a fund; THRL is its ticker on the London Stock Exchange.

**What were THRL’s returns in each of the last five years?**

Calendar-year returns of THRL in pounds (price only, income paid out not included): 2022 −32.0%, 2023 +7.6%, 2024 −2.8%, 2025 +16.7%; 2026 to 13/11/2026 +19.1%. Past performance is not a guide to future returns.

**How has THRL done after inflation?**

Over the five years to 13/11/2026 THRL’s price changed by −1.5% (income paid out is not included), or −23.1% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
